MAPK3 and chronic myelogenous leukemia, BCR-ABL1 positive: However, inhibition of actin cytoskeleton, ERK1/2 and SMAD signaling abrogated the chemoresistance acquisition and sensitized the chemoresistant CML cells to IM induced apoptosis.